Background Mild cognitive impairment (MCI) is a well-known precursor of Alzheimer's
disease (AD) but often also precedes dementia with Lewy bodies (DLB). The early …

Background/Objective: The aim of this study was to describe the rate and clinical predictors
of cognitive decline in dementia with Lewy bodies (DLB), and compare the findings with …

Objective The objective of this study was to examine clinical characteristics, cognitive
decline, and predictors for time to dementia in prodromal dementia with Lewy bodies with …

Dementia with L ewy bodies (DLB) is defined pathologically as neurodegeneration
associated with L ewy bodies (LB). LB‐related symptoms, including olfactory dysfunction …

Objective: To determine whether mild cognitive impairment with Lewy bodies or Alzheimer's
disease differ in their rates of clinical progression to dementia, we undertook longitudinal …

BackgroundThe clinical condition of dementia is now recognized as a diagnosis that can
only be applied too late in the disease process to be useful for therapeutic approaches …

Background: Prodromal dementia with Lewy bodies (DLB) can emerge with the onset of mild
cognitive impairment (MCI). Standard biomarkers can help identify such patients to improve …

Objective To determine whether mild cognitive impairment with Lewy bodies or mild
cognitive impairment with Alzheimer disease differ in their rates of clinical progression to …

Objectives: Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD)
have substantial clinical and biological overlap, with cognitive deficits typically observed in …

Abstract Background Dementia with Lewy Bodies (DLB) is a heterogeneous disease with a
highly variable presentation of core and suggestive symptoms. The relationships between …